Manuka Health has announced its arrival as a serious biotech player with the potential for multi-million dollar exports with new product MGO Manuka Honey with CycloPower.
Manuka honey has been gaining traction as a powerful natural healer for some time. Renowned for its ability to limit the growth of bacteria, manuka honey has often been considered highly-effective, but not life-saving. Manuka Health, a global leader in natural healthcare, says this is all changing.
A discovery by Japanese scientists at Kobe University that a plant derivative, cyclodextrins, could aid the transportation of bio-actives into the body, is bolstering support for manuka honey to make serious inroads into stopping and preventing infections. Manuka Health has combined cyclodextrins (CycloPower) with highly bacteria-resistant manuka honey, which can kill some of the most virulent bacteria.
Researcher Dr Lynne Chepulis says the combination of MGO manuka honey with CycloPower is akin to putting a ball into a bucket. The active properties of the honey can be taken right down into the lower intestine to treat disorders where previously the bioactive molecules would have been destroyed by the body before the journey’s end. The molecules are also released slowly so all of the good stuff is made available to the body.
With virulent anti-biotic resistant bacteria causing havoc in hospitals throughout the world, MGO Manuka and CylcoPower can work as a natural way to stop infections and fill the gap where resistant strains have become highly dangerous.
Dr Chepulis has conducted a series of successful lab tests to prove that MGO Manuka enhanced with CycloPower can eradicate the bacterium that is responsible for causing life-threatening stomach cancers and ulcers, as well as strep throat and scarlet fever.
The potential for not only for medicine, but the New Zealand economy is enormous, with CycloPower products expected to become a multi-million dollar export industry.
“Manuka Health is now poised to position New Zealand at the forefront of not only biotech innovation, but we’re showing the world how to successfully commercialise those discoveries,” said chief executive Kerry Paul.
Paul has been committed to the idea of manuka as a game-changer since he set up the company five years ago, producing pots of honey.
An important aspect of Manuka Health’s export advantage lies in the fact that Chinese health companies cannot copy their products – manuka is native to New Zealand.
Manuka Health has also gone to town with the patenting of its manuka, kiwifruit and propolis products.
Already in 40 countries, the company is tipped to surpass Comvita because of its focus on aiding conventional healthcare.
The main manuka crop used by the company is in Taranaki’s Mt Adams where it is only accessible by crossing 39 rivers and streams.
The finest quality manuka honey with the most potent antimicrobial properties is produced from beehives placed in wild, uncultivated areas with abundant growth of manuka bushes.